The Journal of Immunology, Vol 155, Issue 7 3401-3408, Copyright © 1995 by American Association of Immunologists

ARTICLES

Control of the IL-2 responsiveness of B lymphocytes by IL-2 and IL-4

JL Moreau, P Chastagner, T Tanaka, M Miyasaka, M Kondo, K Sugamura and J Theze
Unit for Cellular Immunogenetics, Pasteur Institute, Paris, France.

A two-step culture system was used to analyze the parameters involved in the acquisition of IL-2 responsiveness by murine B cells. In the first culture, unstimulated, or resting, B cells prepared from spleen of naive animals were challenged during 48 h with IL-2, IL-4, anti-mu, anti-mu+IL-2, anti-mu+IL4, or anti-mu+IL-2 + IL-4. In a second culture, IL-2 responsiveness was followed by measuring either the cell proliferation or the Ig production. It was found that only B cells stimulated by anti-mu+IL-2 were able to respond. The expression of three chains of the IL-2 receptor (IL-2R alpha, IL-2R beta, and IL-2R gamma) was studied by FACS. IL-2R beta and IL-2R gamma were found to be expressed constitutively on resting B cells. IL-2R alpha was induced by anti-mu and anti-mu+IL-2 treatment. Although B cells treated by anti-mu alone are not able to respond to IL-2, they do express an IL-2 binding capacity comparable with B cells treated by anti-mu+IL-2. This paradoxical result suggests that IL-2 has a direct influence on the acquisition of the IL-2 responsiveness. IL-4 exerts a negative effect on the IL-2 response. At the molecular level, IL-4 was found to reduce selectively the IL-2R beta expression at the B cell surface. This effect was confirmed by Northern blot analysis. Maximum expression of the IL-2R beta mRNA is obtained after anti-mu+IL-2 treatment. In the presence of IL-4, expression of the IL-2R beta mRNA is greatly reduced.

This article has been cited by other articles:

				F. Gesbert, J.-L. Moreau, and J. Theze IL-2 Responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2R{beta} transgenic mice Int. Immunol., August 1, 2005; 17(8): 1093 - 1102. [Abstract] [Full Text] [PDF]

				A. L. Mora, J. Youn, A. D. Keegan, and M. Boothby NF-{{kappa}}B/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells J. Immunol., February 15, 2001; 166(4): 2218 - 2227. [Abstract] [Full Text] [PDF]

				Q. Vos, C. M. Snapper, and J. J. Mond Th1 versus Th2 cytokine profile determines the modulation of in vitro T cell-independent type 2 responses by IL-4 Int. Immunol., September 1, 2000; 12(9): 1337 - 1345. [Abstract] [Full Text] [PDF]

				S. Herblot, P. Chastagner, L. Samady, J.-L. Moreau, C. Demaison, P. Froussard, X. Liu, J. Bonnet, and J. Theze IL-2-Dependent Expression of Genes Involved in Cytoskeleton Organization, Oncogene Regulation, and Transcriptional Control J. Immunol., March 15, 1999; 162(6): 3280 - 3288. [Abstract] [Full Text] [PDF]

				C. Johnson-Leger, J. R. Christenson, M. Holman, and G. G. B. Klaus Evidence for a Critical Role for IL-2 in CD40-Mediated Activation of Naive B Cells by Primary CD4 T Cells J. Immunol., November 1, 1998; 161(9): 4618 - 4626. [Abstract] [Full Text] [PDF]

				G. L. Vanham, G. Penne, C. Vereecken, J. Vingerhoets, L. Kestens;, D. David, L. Bani, J.-L. Moreau, and J. Theze Interleukin-2 Receptor Subunit Expression and Function on Human Peripheral T Cells Is Not Dependent on the Anticoagulant Blood, October 15, 1998; 92(8): 2989 - 2993. [Full Text] [PDF]

				D. David, L. Bani, J.-L. Moreau, M.-P. Treilhou, T. Nakarai, M. Joussemet, J. Ritz, B. Dupont, G. Pialoux, and J. Theze Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy PNAS, September 15, 1998; 95(19): 11348 - 11353. [Abstract] [Full Text] [PDF]